Gujarat Terce Laboratories quarterly results and financials

Gujarat Terce Laboratories (BSE 524314)₹45.02−2.76%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Gujarat Terce Laboratories reported sales of ₹8.99 Cr, down 17.1% from Jun 2025, and net profit of −₹0.19 Cr. For the year to Mar 2026, sales were ₹47.39 Cr and net profit ₹2.21 Cr.

Sales (Jun 2026): ₹8.99 Cr
Net profit (Jun 2026): −₹0.19 Cr
Sales (FY Mar 2026): ₹47.39 Cr
Net profit (FY Mar 2026): ₹2.21 Cr
EPS (Jun 2026): ₹−0.22
Borrowings (Mar 2026): ₹1.30 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Gujarat Terce Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Gujarat Terce Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	12.00	12.99	12.19	11.86	13.28	12.66	12.30	10.84	12.90	12.27	11.38	8.99
Expenses	11.49	12.19	11.21	11.82	11.65	11.61	11.28	10.87	11.04	11.17	10.67	9.50
Operating Profit	0.56	0.85	1.02	0.09	1.67	1.09	1.06	−0.02	1.91	1.14	0.75	−0.50
OPM %	4.6%	6.5%	8.3%	0.7%	12.5%	8.5%	8.5%	−0.1%	14.8%	9.2%	6.5%	−5.4%
Other Income	0.07	0.07	0.07	0.06	0.07	0.06	0.08	0.08	0.04	0.12	−0.36	0.47
Interest	0.19	0.15	0.14	0.12	0.12	0.07	0.06	0.04	0.06	0.03	0.02	0.02
Depreciation	0.10	0.10	0.10	0.10	0.10	0.11	0.11	0.11	0.11	0.11	0.14	0.12
Profit before tax	0.35	0.68	0.86	−0.08	1.53	0.98	0.98	−0.08	1.79	1.13	0.22	−0.16
Tax %	0.0%	0.0%	35.3%	14.3%	2.0%	−3.1%	449.4%	−42.9%	21.3%	33.0%	47.6%	19.9%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.34	0.68	0.55	−0.09	1.49	1.02	−3.40	−0.05	1.41	0.77	0.11	−0.19
EPS (Rs)	0.43	0.89	0.72	−0.10	1.98	1.35	−4.56	−0.04	1.88	0.97	0.12	−0.22

Gujarat Terce Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Gujarat Terce Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	24.94	25.26	28.98	30.98	37.50	25.14	40.05	46.72	47.85	50.10	47.39	45.54
Expenses	24.85	25.24	28.72	30.57	36.91	27.76	39.05	48.99	46.66	46.33	43.72	42.38
Operating Profit	0.17	0.09	0.34	0.50	0.69	−2.60	1.12	−2.17	1.28	3.91	3.77	3.30
OPM %	0.6%	0.3%	1.2%	1.6%	1.8%	−10.3%	2.8%	−4.6%	2.7%	7.8%	7.9%	7.3%
Other Income	0.18	0.43	0.40	0.31	0.28	0.61	0.30	0.34	0.31	0.30	−0.11	0.27
Interest	0.37	0.30	0.22	0.24	0.28	0.38	0.39	0.71	0.67	0.41	0.17	0.13
Depreciation	0.20	0.20	0.20	0.22	0.25	0.19	0.29	0.37	0.38	0.39	0.43	0.48
Profit before tax	−0.23	0.03	0.33	0.36	0.45	−2.55	0.75	−2.90	0.55	3.41	3.05	2.98
Tax %	209.0%	149.9%	15.5%	−25.8%	36.3%	−0.4%	−17.7%	−42.3%	55.5%	128.5%	27.3%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	−0.68	−0.02	0.28	0.44	0.29	−2.53	0.88	−1.68	0.25	−0.99	2.21	2.10
EPS (Rs)	−0.89	0.00	0.35	0.57	0.37	−3.39	1.16	−2.24	0.31	−1.31	2.81	2.75
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Gujarat Terce Laboratories balance sheet

₹ crore, at each year end.

Gujarat Terce Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	7.41	7.40	7.40	7.40	7.40	7.40	7.40	7.39	7.41	7.40	7.42	7.77
Reserves	3.61	2.94	2.64	2.97	3.40	3.68	0.24	1.11	−0.57	−0.32	−0.95	1.94
Borrowings	8.19	7.12	6.99	0.37	0.68	2.60	4.73	6.65	7.26	3.86	0.95	1.30
Other Liabilities	7.02	6.94	6.56	8.65	7.90	8.76	9.43	12.13	14.32	12.23	15.33	13.45
Total Liabilities	26.23	24.40	23.59	19.39	19.38	22.44	21.80	27.28	28.42	23.17	22.75	24.46
Fixed Assets	6.47	6.33	6.16	1.87	2.05	2.28	2.44	4.28	3.98	3.68	3.64	3.24
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.31	0.29	0.25	0.28	0.28	0.26	0.28	0.26	0.28	0.26	0.51	1.34
Other Assets	19.45	17.78	17.18	17.24	17.05	19.90	19.08	22.74	24.16	19.23	18.60	19.88
Inventories	4.03	4.28	3.96	3.78	3.79	3.44	3.73	6.44	4.44	3.94	3.67	3.74
Trade receivables	9.19	8.49	7.91	4.59	4.52	7.00	5.16	5.48	8.00	5.65	5.06	4.88
Cash & equivalents	1.85	0.46	0.52	0.72	0.17	0.03	1.28	1.50	2.02	0.08	0.77	2.85
Total Assets	26.23	24.40	23.59	19.39	19.38	22.44	21.80	27.28	28.42	23.17	22.75	24.46

Gujarat Terce Laboratories cash flow

₹ crore, for each year.

Gujarat Terce Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	1.37	0.15	0.23	4.56	−0.60	−1.58	−0.15	−0.43	0.02	2.59	3.05	1.70
Cash from investing activity	0.09	−0.12	0.17	1.12	−0.12	−0.26	−0.43	−0.86	0.61	−0.47	0.45	−0.12
Cash from financing activity	−0.74	−1.44	−0.37	−5.40	0.21	1.73	1.84	1.54	−0.13	−4.09	−2.84	0.48
Net cash flow	0.74	−1.40	0.07	0.30	−0.56	−0.15	1.25	0.23	0.53	−1.95	0.70	2.09
Capex	0.65	0.07	0.02	0.29	0.41	0.49	0.51	2.12	0.07	0.08	0.00	0.04
Free cash flow	0.91	0.09	0.24	4.44	−1.00	−2.08	−0.65	−2.54	−0.04	2.54	3.42	1.68
CFO / OP %	191.0%	406.0%	688.0%	1,418.0%	−98.0%	−219.0%	0.0%	−31.0%	−3.0%	205.0%	81.0%	45.1%

Gujarat Terce Laboratories ratios

Working-capital days and returns, by year.

Gujarat Terce Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	127	124	114	58	53	68	75	50	62	43	37	37
Inventory days	143	163	150	126	115	90	137	154	84	81	71	79
Days payable	88	92	60	111	85	83	104	96	110	97	70	34
Cash conversion cycle	182	195	206	74	84	76	108	108	37	28	39	84
Working capital days	98	112	88	22	29	26	−13	8	−19	−7	−13	−5
ROCE %	3.4%	0.9%	1.9%	3.0%	5.4%	5.8%	−15.1%	8.3%	−14.8%	9.8%	41.4%	39.3%

Gujarat Terce Laboratories: frequently asked questions

What are the latest quarterly results of Gujarat Terce Laboratories?

For the Jun 2026 quarter, Gujarat Terce Laboratories reported sales of ₹8.99 Cr, down 17.1% year on year and net profit of −₹0.19 Cr. The operating margin was −5.4%.

What is the annual revenue of Gujarat Terce Laboratories?

Gujarat Terce Laboratories' sales for the year to Mar 2026 were ₹47.39 Cr; over the last twelve months they were ₹45.54 Cr.

What is the net profit of Gujarat Terce Laboratories?

Net profit for the year to Mar 2026 was ₹2.21 Cr, and ₹2.10 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.75.

How much debt does Gujarat Terce Laboratories have?

Gujarat Terce Laboratories reported borrowings of ₹1.30 Cr at Mar 2026, against cash and equivalents of ₹2.85 Cr.

What is the free cash flow of Gujarat Terce Laboratories?

Cash from operations was ₹1.70 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.68 Cr.

Loading…